Analysis of soil and sediment
IVL Swedish Environmental Research Institute has extensive experience of environmental pollution in soil and sediment and conducts sampling, analyzes and provides advice on proposed action plans.
One of our areas of expertise is pollution of PFAS in soil. We specialize in analyzing very low levels of PAH, PCB, PFAS and mercury, among other things, and follow trends around levels in the environment.
The analyzes and tests are done in our analysis laboratory and tailored to your needs. Many of our measurement and analysis methods are accredited by Swedac
External link, opens in new window. according to SS-EN ISO / IEC 17025: 2018. For other methods, we work based on corresponding quality routines.
Hire IVL for:
- Sampling plans, sampling and analyzes of soil and sediment
- Plausibility assessments
- Risk assessments
- Advice on proposals for action plans.
Ämnen vi mäter
Uppgifterna nedan om mätområde och mätosäkerhet är ungefärliga. För aktuella uppgifter kontakta kontaktpersonen ovan.
OORGANISKA ANALYSER AV VATTEN, SLAM OCH BIOTA | ||||||
|---|---|---|---|---|---|---|
Analyt | Metod | Enhet | LOD | LOQ | Mätosäkerhet | Ackrediterad |
kvicksilver, totalt i fasta material | CVAFS | ng/g | 0.03 | 0.1 | 15% | ja |
metylkvicksilver i fasta material | CVAFS | ng/g | 0.02 | 0.06 | 15% | ja |
ORGANISKA ANALYSER | ||||||
|---|---|---|---|---|---|---|
Analyt | Metod | Enhet | LOD | LOQ | Mätosäkerhet | Ackrediterad |
PCB 28 | PCB på GC-EC | ng/prov | 0.15 | 0.4 | 30% | ja |
PCB 52 | PCB på GC-EC | ng/prov | 0.1 | 0.4 | 30% | ja |
PCB 101 | PCB på GC-EC | ng/prov | 0.1 | 0.4 | 30% | ja |
PCB 118 | PCB på GC-EC | ng/prov | 0.1 | 0.3 | 30% | ja |
PCB 138 | PCB på GC-EC | ng/prov | 0.05 | 0.3 | 30% | ja |
PCB 153 | PCB på GC-EC | ng/prov | 0.1 | 0.3 | 30% | ja |
PCB 180 | PCB på GC-EC | ng/prov | 0.05 | 0.3 | 30% | ja |
Antracen | PAH, HPLC-fluorescens | ng/prov | 0.04 | 0.15 | 65% | ja |
Benso(a)-antracen | PAH, HPLC-fluorescens | ng/prov | 0.2 | 0.6 | 40% | ja |
Benso(a)-pyren | PAH, HPLC-fluorescens | ng/prov | 0.15 | 0.5 | 30% | ja |
Benso(b)-flouranten | PAH, HPLC-fluorescens | ng/prov | 0.2 | 0.7 | 30% | ja |
Benso(ghi)-perylen | PAH, HPLC-fluorescens | ng/prov | 0.3 | 1 | 30% | ja |
Benso(k)-flouranten | PAH, HPLC-fluorescens | ng/prov | 0.1 | 0.4 | 40% | ja |
Krysen | PAH, HPLC-fluorescens | ng/prov | 0.15 | 0.55 | 30% | ja |
Dibenso(a,h)-antracen | PAH, HPLC-fluorescens | ng/prov | 0.2 | 0.5 | 40% | ja |
Fenantren | PAH, HPLC-fluorescens | ng/prov | 0,6 | 2 | 55% | ja |
Fluoranten | PAH, HPLC-fluorescens | ng/prov | 0.4 | 1.2 | 30% | ja |
Indeno(cd)-pyren | PAH, HPLC-fluorescens | ng/prov | 0.6 | 2 | 30% | ja |
Pyren | PAH, HPLC-fluorescens | ng/prov | 0.5 | 1.3 | 40% | ja |
ORGANISKA ANALYSER AV SEDIMENT | ||||||
|---|---|---|---|---|---|---|
Analyt | Metod | Enhet | LOD | LOQ | Mätosäkerhet | Ackrediterad |
Bekämpningsmedel | ||||||
Diuron | 11 | ng/g TS | 0,05 | 0,15 | ca 30-40% | nej |
Simazin | 11 | ng/g TS | 0,1 | 0,5 | ca 30-40% | nej |
a-HCH | 5 | ng/g TS | 0,0030 | 0,010 | ±40% | nej |
b-HCH | 5 | ng/g TS | 0,0060 | 0,020 | ±40% | nej |
g-HCH | 5 | ng/g TS | 0,0030 | 0,010 | ±40% | nej |
p,p-DDT | 5 | ng/g TS | 0,0060 | 0,020 | ±40% | nej |
o,p-DDT | 5 | ng/g TS | 0,012 | 0,040 | ej beräknad | nej |
p,p-DDE | 5 | ng/g TS | 0,0060 | 0,020 | ±40% | nej |
p,p-DDD | 5 | ng/g TS | 0,0060 | 0,020 | ±40% | nej |
Cybutryn (irgarol) | 11 | ng/g TS | - | - | ca 30-40% | nej |
Övriga klorerade | ||||||
Hexaklorbensen(HCB) | 5 | ng/g TS | 0,0060 | 0,020 | 30% | nej |
Hexaklorbutadien(HCBD) | 5b | ng/g TS | 1 | 3 | 30% | nej |
trans-nonaklor | 5 | ng/g TS | 0,0030 | 0,010 | 30% | nej |
alfa-klordan | 5 | ng/g TS | 0,0030 | 0,010 | 30% | nej |
gamma-klordan | 5 | ng/g TS | 0,0030 | 0,010 | 30% | nej |
1,2,3-Triklorbensen | 5b | ng/g TS | 0,05 | 0,2 | 30% | nej |
1,2,4-Triklorbensen | 5b | ng/g TS | 0,05 | 0,2 | 30% | nej |
1,3,5-Triklorbensen | 5b | ng/g TS | 0,05 | 0,2 | 30% | nej |
Bromerade difenyletrar | ||||||
PBDE 28 | 5 | ng/g TS | 0,0075 | 0,025 | 30% | nej |
PBDE 47 | 5 | ng/g TS | 0,0060 | 0,020 | 30% | nej |
PBDE 66 | 5 | ng/g TS | - | - | ej beräknad | nej |
PBDE-85 | 5 | ng/g TS | 0,0075 | 0,025 | 30% | nej |
PBDE-99 | 5 | ng/g TS | 0,0060 | 0,020 | 30% | nej |
PBDE-100 | 5 | ng/g TS | 0,0060 | 0,020 | 30% | nej |
PBDE 153 | 5 | ng/g TS | 0,0075 | 0,025 | 30% | nej |
PBDE 154 | 5 | ng/g TS | 0,0075 | 0,025 | 30% | nej |
PBDE 183 | 5a | ng/g TS | 0,03 | 0,1 | 30% | nej |
PBDE 209 | 5a | ng/g TS | 0,3 | 1 | 30% | nej |
Organiska tennföreningar | ||||||
Tributyltennföreningar | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Dioktyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Monobutyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Monofenyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Monooktyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Tricyclohexyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Trifenyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Tetrabutyltenn | substansen förloras vid frystorkning, ingår därför ej i analyspaketet | ng/g TS | - | - | nej | |
Dibutyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Difenyltenn | 12 | ng/g TS | 0,3 | 1 | ca ±30% | nej |
Perfluorerade föreningar | ||||||
Perfluorooctane sulfonic acid (PFOS) | 1 | ng/g TS | 0,1 | 0,3 | ca ±20% | nej |
Perfluoroctanoicacid(PFOA) | 1 | ng/g TS | 0,1 | 0,3 | ca ±20% | nej |
Perfluorobutansulfonat | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorohexansulfonat | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluoroktansulfonat | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorodekansulfonat | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorooktansulfonamid | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorohexansyra | 1 | ng/g TS | 0.3 | 0.9 | ca ±20% | nej |
Perfluoroheptansyra | 1 | ng/g TS | 0.05 | 0.15 | ca ±20% | nej |
Perfluorooktansyra | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorononansyra | 1 | ng/g TS | 0,1 | 0.3 | ca ±20% | nej |
Perfluorodekansyra | 1 | ng/g TS | 0.05 | 0.15 | ca ±20% | nej |
Perfluoroundekansyra | 1 | ng/g TS | 0.05 | 0.15 | ca ±20% | nej |
Nonylphenol | ||||||
4-n-nonylfenol-4 | 2 | ng/g TS | 0,2 | 1 | ca 40% | nej |
nonylphenol(branched) | 2 | ng/g TS | 10 | 30 | ca 40% | nej |
Octylphenols | ||||||
4-n-octylphenol | 2 | ng/g TS | 0,2 | 1 | ca 40% | nej |
4-tert-octylphenol-5 | 2 | ng/g TS | 0,2 | 1 | ca 40% | nej |
Di(2-etylhexyl)ftalat(DEHP) | 3 | ng/g TS | 10 | 30 | ca 20% | nej |
Bisfenol A | GC-MS/MS QQQ | ng/g TS | 5 | 15 | ca 30% | nej |
Dessa kan erbjudas i samma analys som DEHP | 12-50% | nej | ||||
HBCDD | 5a | ng/g TS | 0,3 | 1 | ca 40% | nej |
Alfa-Endosulfan | 4a | ng/g TS | 0,05 | 0,2 | ca 40% | nej |
Beta-Endosulfan | 4a | ng/g TS | 0,05 | 0,2 | ca 40% | nej |
Endosulfansulfat | 4a | ng/g TS | 0,05 | 0,2 | ca 40% | nej |
Mjukgörare | * ej fastställt | |||||
Dietylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Di-n-butylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Diisobutylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Butylbensylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Di(2-etylhexyl)ftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Bis(2-ethylhexyl) adipate | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Diisononylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Diisodecylftalat | GC-MS/MS QQQ | ng/g TS | 30 | 100 | * | nej |
Di-n-propylftalat | GC-MS/MS QQQ | ng/g TS | 30 | 100 | * | nej |
Dimetylftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Tributyl O-acetylcitrate | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Bis(2-propylheptyl) ftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Diisononylcyclohexane-1,2-dicarboxylate | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Bis(2-ethylhexyl) terelftalat | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Dicyclohexyl phthalate | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
UV-Filter | ||||||
2-Ethylhexyl salicylate | GC-MS/MS QQQ | ng/g TS | 7 | 24 | * | nej |
Homomenthyl salicylate | GC-MS/MS QQQ | ng/g TS | 2 | 7 | * | nej |
3-Benzylidene camphor | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
4-Methyl benzylidene camphor | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
Benzophenon-3 | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
2,4-Dihydroxybensophenone | GC-MS/MS QQQ | ng/g TS | 3 | 9 | * | nej |
2,2´-Dihydroxy-4-metoxybensophenone | GC-MS/MS QQQ | ng/g TS | 10 | 30 | * | nej |
Ethylhexyl p-dimethylaminobenzoat | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
Diethylamino hydroxybenzoylhexyl benzoate | GC-MS/MS QQQ | ng/g TS | * | nej | ||
Isoamyl p-methoxycinnamate | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
Octyl methoxycinnamate | GC-MS/MS QQQ | ng/g TS | 0.4 | 1 | * | nej |
Octocrylene | GC-MS/MS QQQ | ng/g TS | 6 | 20 | * | nej |
Benzophenone | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
Dihydroactinidiolide | GC-MS/MS QQQ | ng/g TS | 0.04 | 0.1 | * | nej |
Benzene, 1,1'-(3,3-dimethyl-1-butenylidene)bis 1,1,3-Trimethyl-3-phenylindan | GC-MS/MS QQQ | ng/g TS | 3 | 10 | * | nej |
2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol | GC-MS/MS QQQ | ng/g TS | 6 | 20 | * | nej |
2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol | GC-MS/MS QQQ | ng/g TS | 3 | 10 | * | nej |
2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol | GC-MS/MS QQQ | ng/g TS | 5 | 15 | * | nej |
2-(benzotriazol-2-yl)-4-methylphenol | GC-MS/MS QQQ | ng/g TS | 4 | 12 | * | nej |
Etylhexyl triazone | HPLC MS/MS | ng/g TS | 10 | 30 | * | nej |
Bemotrizinol | HPLC MS/MS | ng/g TS | 3 | 10 | * | nej |
Bisoctriazol | HPLC MS/MS | ng/g TS | 1 | 3 | * | nej |
Diethylhexyl butamidotri-azone | HPLC MS/MS | ng/g TS | 4 | 12 | * | nej |
Läkemedel | ||||||
Amlodipine | HPLC-MS/MS | ng/g TS | 10 | 13 | Nej | |
Atenolol | HPLC-MS/MS | ng/g TS | 2 | 14 | Nej | |
Bisoprolol | HPLC-MS/MS | ng/g TS | 25 | 2.3 | Nej | |
Caffeine | HPLC-MS/MS | ng/g TS | 10 | 1.6 | Nej | |
Carbamazepine | HPLC-MS/MS | ng/g TS | 5 | 2.2 | Nej | |
Citalopram | HPLC-MS/MS | ng/g TS | 5 | 1.8 | Nej | |
Diclofenac | HPLC-MS/MS | ng/g TS | 25 | 1.8 | Nej | |
Fluoxetine | HPLC-MS/MS | ng/g TS | 21 | - | Nej | |
Furosemide | HPLC-MS/MS | ng/g TS | 25 | 2.8 | Nej | |
Hydrochlorothiazide | HPLC-MS/MS | ng/g TS | 2 | 9.3 | Nej | |
Ibuprofen | HPLC-MS/MS | ng/g TS | 10 | 4 | Nej | |
Ketoprofen | HPLC-MS/MS | ng/g TS | 50 | 3.8 | Nej | |
Metoprolol | HPLC-MS/MS | ng/g TS | 2 | 2.2 | Nej | |
Naproxen | HPLC-MS/MS | ng/g TS | 15 | 6.2 | Nej | |
Oxazepam | HPLC-MS/MS | ng/g TS | 5 | 3.9 | Nej | |
Paracetamol | HPLC-MS/MS | ng/g TS | 75 | 15 | Nej | |
Propranolol | HPLC-MS/MS | ng/g TS | 2 | 4 | Nej | |
Ramipril | HPLC-MS/MS | ng/g TS | 25 | 14 | Nej | |
Ranitidine | HPLC-MS/MS | ng/g TS | - | 21 | Nej | |
Risperidone | HPLC-MS/MS | ng/g TS | 6 | - | Nej | |
Sertraline | HPLC-MS/MS | ng/g TS | 3 | 5.6 | Nej | |
Simvastatin | HPLC-MS/MS | ng/g TS | 200 | 12 | Nej | |
Terbutaline | HPLC-MS/MS | ng/g TS | 40 | 7 | Nej | |
Warfarin | HPLC-MS/MS | ng/g TS | 10 | 0.4 | Nej | |
Antibiotika | * ej fastställt | |||||
Benzylpenicillin | HPLC-MS/MS | ng/g TS | 30 | * | Nej | |
Fusidic acid | HPLC-MS/MS | ng/g TS | 12 | * | Nej | |
Rifampicin | HPLC-MS/MS | ng/g TS | 16 | * | Nej | |
Sulfamethoxazole | HPLC-MS/MS | ng/g TS | 9 | * | Nej | |
Ciprofloxacin | HPLC-MS/MS | ng/g TS | 19 | * | Nej | |
Claritromycin | HPLC-MS/MS | ng/g TS | 9 | * | Nej | |
Clindamycin | HPLC-MS/MS | ng/g TS | 10 | * | Nej | |
Doxycycline | HPLC-MS/MS | ng/g TS | 25 | * | Nej | |
Linezolid | HPLC-MS/MS | ng/g TS | 12 | * | Nej | |
Moxifloxacin | HPLC-MS/MS | ng/g TS | 14 | * | Nej | |
Norfloxacin | HPLC-MS/MS | ng/g TS | 21 | * | Nej | |
Tetracycline | HPLC-MS/MS | ng/g TS | 11 | * | Nej | |
Trimetoprim | HPLC-MS/MS | ng/g TS | 11 | * | Nej | |
Hormoner | ||||||
Estrone | GC-MS | ng/g TS | 1 | 3 | - | Nej |
β-Estradiol | GC-MS | ng/g TS | 1 | 3 | - | Nej |
Ethynylestradiol | GC-MS | ng/g TS | 13 | 40 | - | Nej |
Klorfenoler | ||||||
2,6-DCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
2,4-/2,5-DCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
2.3-DCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
3,5-DCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
3,4-DCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
246-TCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
236-TLP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
245-TLP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
234-TCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
345-TCP | GC-MS/MS QQQ | ng/g TS | 1 | ca 30% | Nej | |
2356-TeCP | GC-MS/MS QQQ | ng/g TS | 0.3 | ca 30% | Nej | |
2346-TeCP | GC-MS/MS QQQ | ng/g TS | 0.3 | ca 30% | Nej | |
2345-TeCP | GC-MS/MS QQQ | ng/g TS | 0.3 | ca 30% | Nej | |
PCP | GC-MS/MS QQQ | ng/g TS | 0.3 | ca 30% | Nej | |